Recent Commentaries tagged (bsx)
Earnings Scorecard: St. Jude - Analyst Blog
Medical devices major St. Jude Medical's (STJ) fourth-quarter 2011 adjusted earnings per share of 86 cents beat the Zacks Consensus Estimate by a couple of cents and exceeded the year-ago earnings of 75 cents. Highlights from the Quarter Profit (as reported) for the fourth quarter slipped roughl...
Read More »
Tags: analyst-blog | bsx | mdt | stj | stocks
AngioDynamics to Buy Navilyst - Analyst Blog
In a bid to bolster its vascular business, therapeutic and diagnostic devices maker AngioDynamics (ANGO) has agreed to buy Massachusetts-based privately held Navilyst Medical in a cash and stock deal. Navilyst Medical, which focuses in the vascular access, interventional radiology and interventio...
Read More »
Tags: analyst-blog | ango | bac | bcr | bcs | bsx | jpm | stocks
Positive Outcome on MDT's CoreValve -...
Leading medical device player Medtronic (MDT) recently came out with the results of two studies conducted on the company's CoreValve System delivered through the direct aortic implantation approach. The data demonstrated at the 48th Annual Meeting of the Society of Thoracic Surgeons (STS) showed ...
Read More »
Tags: analyst-blog | bsx | ew | mdt | stj | stocks
BSX Disappoints, Guidance Weak - Ahead of...
The challenges of Boston Scientific Corporation's (BSX) core segments consisting of stents and defibrillators do not show any sign of abatement. Revenues declined 8% year over year to $1.848 billion during the fourth quarter 2011 and missed the Zacks Consensus Estimate of $1.908 billion. Excludin...
Read More »
Tags: ahead-of-wall-street | bsx | stj | stocks
Bard Tops in 4Q, Charges Crimp Net - Analyst...
Leading medical devices maker C. R. Bard's (BCR) adjusted earnings for fourth-quarter fiscal 2011 topped expectation but lofty charges dragged down its profits for the quarter. The New Jersey-based company posted adjusted earnings of $1.70 a share which beat the Zacks Consensus Estimate of $1.68 ...
Read More »
Tags: analyst-blog | ango | bcr | bsx | jnj | stocks
Earnings Preview: C.R. Bard - Analyst Blog
Leading medical devices maker C.R. Bard (BCR) is scheduled to report its fourth quarter and fiscal 2011 results after the closing bell on Tuesday, January 31. The New Jersey-based company envisions its sales for the fourth quarter would grow 3%-5% in constant currency with new acquisitions contri...
Read More »
Tags: analyst-blog | ango | bcr | bsx | jnj | stocks
Earnings Preview: Boston Scientific -...
Boston Scientific (BSX) is scheduled to release its fourth quarter and fiscal 2011 earnings on Thursday, February 2, 2012, before the market opens. The company is expected to report EPS of 8 cents on revenue of $1.908 billion for the quarter and EPS of 44 cents on revenue of $7.662 billion during...
Read More »
Tags: analyst-blog | bsx | mdt | stj | stocks
AngioDynamics Cuts View on Recall - Analyst Blog
Therapeutic and diagnostic devices maker AngioDynamics (ANGO) has trimmed its sales and earnings outlook for fiscal 2012 based on the recent voluntary recall, in the U.S, of the ablation zone estimator ("AZE") software for its tumor-zapping NanoKnife systems. The recall has resulted in a momentar...
Read More »
Tags: analyst-blog | ango | bcr | bsx | stocks
MDT Advances in CoreValve US Trial - Analyst...
Leading medical devices player, Medtronic (MDT) has taken one step forward in its CoreValve US pivotal trial with completion of enrollment in the extreme risk category of patients. The company has also received approval from the US Food and Drug Administration ("FDA") to continue enrolling extr...
Read More »
Tags: analyst-blog | bsx | mdt | stj
Tuebingen UMS Deploys BSD's System - Analyst...
Cancer treatment systems maker BSD Medical (BSDM) said that Germany-based Tuebingen University Medical School ("Tuebingen UMS") has purchased and installed its BSD-2000/3D/MR hyperthermia system. The device was purchased, in June 2011, by the company's European distributor Dr. Sennewald Medizinte...
Read More »
Tags: analyst-blog | ango | bsdm | bsx | si | stocks
